Con: Liver Biopsy Remains the Gold Standard to Evaluate Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- PMID: 31061705
- PMCID: PMC6491029
- DOI: 10.1002/cld.740
Con: Liver Biopsy Remains the Gold Standard to Evaluate Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
References
-
- Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease: meta‐analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73‐84. - PubMed
-
- Castera L, Foucher J, Bernard PH. Pitfalls of liver stiffness measurement: a 5‐year prospective study of 13,369 examinations. Hepatology 2010;51:828‐835. - PubMed
-
- Imajo K, Kessoku T, Honda Y, et al. Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography. Gastroenterology 2016;150:e7. - PubMed
Publication types
LinkOut - more resources
Full Text Sources